Bayesian Capital Management, LP / PFE
Bayesian Capital Management, LP’s Pfizer Inc Position
Does Bayesian Capital Management, LP own Pfizer Inc (PFE)? Yes — 46.7K shares worth $1M (+1.60% of its 13F portfolio) as of Q1 2026, down from 98.2K shares the prior filed quarter.
Position Value
$1M
Q1 2026
Shares
46.7K
% of Portfolio
+1.60%
Quarters Held
18
currently held
Position History PFE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 46.7K | $1M | +1.60% |
| Q2 2025 | 98.2K | $2M | +0.38% |
| Q1 2025 | 153.2K | $4M | +0.64% |
| Q4 2024 | 181.6K | $5M | +0.59% |
| Q3 2024 | 140.8K | $4M | +0.48% |
| Q2 2024 | 55.1K | $2M | +0.18% |
| Q1 2024 | 220.0K | $6M | +0.58% |
| Q4 2023 | 175.2K | $5M | +0.54% |
| Q3 2023 | 111.6K | $4M | +0.42% |
| Q2 2023 | 60.3K | $2M | +0.24% |
| Q1 2023 | 24.5K | $999,600 | +0.12% |
| Q2 2022 | 18.4K | $965,000 | +0.18% |
| Q4 2021 | 6.0K | $354,000 | +0.11% |
| Q3 2021 | 34.9K | $2M | +0.43% |
| Q2 2021 | 35.7K | $1M | +0.37% |
| Q1 2021 | 96.3K | $3M | +0.80% |
| Q4 2020 | 48.7K | $2M | +0.47% |
| Q1 2020 | 85.4K | $3M | +0.60% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bayesian Capital Management, LP’s full portfolio or all institutional holders of PFE.